Kiora Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 3.57 million compared to USD 2.01 million a year ago. Basic loss per share from continuing operations was USD 10.8 compared to USD 10.8 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.536 USD | -1.81% | -1.13% | +5.78% |
05-10 | Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M | MT |
03-25 | Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.78% | 14.33M | |
+9.80% | 118B | |
+10.25% | 106B | |
-11.83% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.81% | 15.97B | |
+6.16% | 14.03B | |
+14.70% | 11.67B |
- Stock Market
- Equities
- KPRX Stock
- News Kiora Pharmaceuticals, Inc.
- Kiora Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022